How ghost-writing threatens the credibility of medical knowledge and medical journals

被引：20

作者：

Barbour, Virginia ^{[1
]}

机构：

[1] PLoS Med, Publ Lib Sci, Cambridge, England

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 01期

关键词：

ROFECOXIB LITIGATION; DOCUMENTS;

D O I：

10.3324/haematol.2009.017426

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 2

页数：2

共 6 条

[1] "Ghostbusting" at Blood [J].

Dunbar, Cynthia E. ;

Tallman, Martin S. .

BLOOD, 2009, 113 (03) :502-503

[2] Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals [J].

Flanagin, A ;

Carey, LA ;

Fontanarosa, PB ;

Phillips, SG ;

Pace, BP ;

Lundberg, GD ;

Rennie, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (03) :222-224

[3] Ghost authorship in industry-initiated randomised trials [J].

Gotzsche, Peter C. ;

Hrobjartsson, Asbjorn ;

Johansen, Helle Krogh ;

Haahr, Mette T. ;

Altman, Douglas G. ;

Chan, An-Wen .

PLOS MEDICINE, 2007, 4 (01) :47-52

[4]

PLoS Medicine editors, 2009, PLOS MED, V6

[5] Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment - A case study based on documents from rofecoxib litigation [J].

Psaty, Bruce M. ;

Kronmal, Richard A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (15) :1813-1817

[6] Guest authorship and ghostwriting in publications related to rofecoxib - A case study of industry documents from rofecoxib litigation [J].

Ross, Joseph S. ;

Hill, Kevin P. ;

Egilman, David S. ;

Krumholz, Harlan M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (15) :1800-1812

← 1 →